Skip to content

FDM PHARMA: what changed

BE 0546.573.521NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€357,146
2024 · €308,750+€48,396
Equity
€1.8m
2024 · €1.5m+€357,146
Cash
€537,485
2024 · €1.2m-€632,718
Balance sheet total
€2.8m
2024 · €3.3m-€426,529

Largest movements

2024 to 2025
Assets
  • Cash -€632,718

    down €632,718 (-54.1%), from €1.2m to €537,485

    mainly Current investments (-€500,000) and Other debts (-€361,868)

  • Current investments +€500,000

    first reported in 2025, at €500,000

  • Intangible fixed assets -€238,293

    down €238,293 (-44.0%), from €541,936 to €303,642

  • Tangible fixed assets -€62,718

    down €62,718 (-11.5%), from €544,197 to €481,479

    of which Other tangible fixed assets: -€32,496

Equity and liabilities
  • Other debts -€361,868

    down €361,868 (-99.8%), from €362,567 to €699

  • Reserves +€357,146

    up €357,146 (+32.0%), from €1.1m to €1.5m

    of which Distributable reserves: +€230,846

  • Trade debts -€216,215

    down €216,215 (-75.4%), from €286,590 to €70,376

  • Debts after one year -€168,918

    down €168,918 (-20.2%), from €837,320 to €668,402

Income statement
  • Gross operating margin +€144,675

    up €144,675 (+16.1%), from €899,567 to €1.0m

  • Staff costs +€76,595

    up €76,595 (+95.3%), from €80,333 to €156,927

  • Taxes +€19,170

    up €19,170 (+10.9%), from €175,207 to €194,377

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €308,750
Gross operating margin +€144,675
Staff costs -€76,595
Depreciation -€1,227
Other operating charges -€1,717
Financial income -€1,258
Financial charges +€3,687
Taxes -€19,170
Result 2025 €357,146
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€57,819
Investment -€502,390
Financing -€188,148
Cash 2024 €1.2m
Net result for the year +€357,146
Depreciation +€303,401
Stocks and contracts -€29,665
Receivables within one year +€4,643
Deferred charges and accrued income +€17,822
Trade debts -€216,215
Tax, wage and social debts -€17,445
Other debts -€361,868
Investment in fixed assets (net) -€2,390
Current investments -€500,000
Debts after one year -€168,918
Current portion of long-term debt -€19,230
Cash 2025 €537,485
brings cash intakes cash out
Every line side by side 52 lines
Line Code 2024 2025 Change %
Total assets 20/58 €3,266,880 €2,840,351 -€426,529 -13.1%
Fixed assets 21/28 €1,520,873 €1,219,862 -€301,011 -19.8%
Intangible fixed assets 21 €541,936 €303,642 -€238,293 -44.0%
Tangible fixed assets 22/27 €544,197 €481,479 -€62,718 -11.5%
Land and buildings 22 €130,890 €120,263 -€10,627 -8.1%
Plant, machinery and equipment 23 €14,636 €12,215 -€2,422 -16.5%
Furniture and vehicles 24 €14,535 €12,217 -€2,318 -15.9%
Leasing and similar rights 25 €91,731 €76,876 -€14,856 -16.2%
Other tangible fixed assets 26 €292,404 €259,909 -€32,496 -11.1%
Financial fixed assets 28 €434,741 €434,741 = 0.0%
Current assets 29/58 €1,746,007 €1,620,489 -€125,518 -7.2%
Stocks and contracts in progress 3 €300,365 €330,031 +€29,665 +9.9%
Stocks 30/36 €300,365 €330,031 +€29,665 +9.9%
Amounts receivable within one year 40/41 €30,144 €25,501 -€4,643 -15.4%
Trade receivables 40 €21,570 €13,893 -€7,677 -35.6%
Other amounts receivable 41 €8,574 €11,608 +€3,034 +35.4%
Current investments 50/53 - €500,000 +€500,000
Cash at bank and in hand 54/58 €1,170,203 €537,485 -€632,718 -54.1%
Deferred charges and accrued income 490/1 €245,294 €227,472 -€17,822 -7.3%
Total equity and liabilities 10/49 €3,266,880 €2,840,351 -€426,529 -13.1%
Equity 10/15 €1,492,686 €1,849,832 +€357,146 +23.9%
Contributions 10/11 €14,260 €14,260 = 0.0%
Reserves 13 €1,114,745 €1,471,890 +€357,146 +32.0%
Tax-exempt reserves 132 €84,200 €210,500 +€126,300 +150%
Distributable reserves 133 €1,030,545 €1,261,390 +€230,846 +22.4%
Profit (loss) carried forward 14 €363,682 €363,682 = 0.0%
Amounts payable 17/49 €1,774,193 €990,519 -€783,675 -44.2%
Amounts payable after more than one year 17 €837,320 €668,402 -€168,918 -20.2%
Financial debts 170/4 €837,320 €668,402 -€168,918 -20.2%
Amounts payable within one year 42/48 €936,873 €322,116 -€614,757 -65.6%
Current portion of amounts payable after more than one year 42 €187,001 €167,771 -€19,230 -10.3%
Trade debts 44 €286,590 €70,376 -€216,215 -75.4%
Suppliers 440/4 €286,590 €70,376 -€216,215 -75.4%
Taxes, remuneration and social security 45 €100,716 €83,271 -€17,445 -17.3%
Taxes 450/3 €81,338 €52,263 -€29,074 -35.7%
Remuneration and social security 454/9 €19,378 €31,008 +€11,630 +60.0%
Other amounts payable 47/48 €362,567 €699 -€361,868 -99.8%
Accrued charges and deferred income 492/3 €0 - =
Remuneration, social security and pensions 62 €80,333 €156,927 +€76,595 +95.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €302,174 €303,401 +€1,227 +0.4%
Other operating charges 640/8 €4,287 €6,004 +€1,717 +40.1%
Gross operating margin 9900 €899,567 €1,044,242 +€144,675 +16.1%
Operating profit (loss) 9901 €512,774 €577,910 +€65,136 +12.7%
Financial income 75/76B €4,548 €3,291 -€1,258 -27.6%
Recurring financial income 75 €4,548 €3,291 -€1,258 -27.6%
Financial charges 65/66B €33,365 €29,677 -€3,687 -11.1%
Recurring financial charges 65 €33,365 €29,677 -€3,687 -11.1%
Profit (loss) for the period before taxes 9903 €483,957 €551,523 +€67,566 +14.0%
Income taxes 67/77 €175,207 €194,377 +€19,170 +10.9%
Profit (loss) for the period 9904 €308,750 €357,146 +€48,396 +15.7%
Transfer to tax-exempt reserves 689 €84,200 €126,300 +€42,100 +50.0%
Profit (loss) for the period to be appropriated 9905 €224,550 €230,846 +€6,296 +2.8%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€1.9m to €2.3m

Midpoint €2.1m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €1.5m
Capitalised earnings €2.2m to €3.1m
Indication €1.9m to €2.3m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€1,849,832
Intangible fixed assets (21)
-€303,642
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€1.5m

Capitalised earnings

net result for the year (9904)
2025
€357,146
2024
€308,750
2023
€278,226
2022
€234,549
2021
€131,710
Average result
€314,707
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€2.2m / €2.6m / €3.1m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.